FDA Inspection 1240683 — KUPI Reproductive Endocrinology & Infertility Lab

KUPI Reproductive Endocrinology & Infertility Lab — FEI 3003934351

The FDA completed an inspection of KUPI Reproductive Endocrinology & Infertility Lab on May 16, 2024 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 16, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Overland Park, KS (United States)